Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 246

    1.

    Narrative review: drug-eluting stents for the management of restenosis: a critical appraisal of the evidence.

    Tung R, Kaul S, Diamond GA, Shah PK.

    Ann Intern Med. 2006 Jun 20;144(12):913-9. Review.PMID: 16785479 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

    Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB.

    N Engl J Med. 2007 Mar 8;356(10):998-1008. Epub 2007 Feb 12.PMID: 17296824 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

    Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A.

    N Engl J Med. 2007 Mar 8;356(10):1030-9. Epub 2007 Feb 12.PMID: 17296823 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.

    Ray GM, Nawarskas JJ, Frishman WH.

    Cardiol Rev. 2006 May-Jun;14(3):143-50. Review.PMID: 16628023 [PubMed - indexed for MEDLINE]Related articles

    5.

    Stent thrombosis in randomized clinical trials of drug-eluting stents.

    Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE.

    N Engl J Med. 2007 Mar 8;356(10):1020-9. Epub 2007 Feb 12.PMID: 17296821 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A systematic review and economic analysis of drug-eluting coronary stents available in Australia.

    Lord SJ, Howard K, Allen F, Marinovich L, Burgess DC, King R, Atherton JJ.

    Med J Aust. 2005 Nov 7;183(9):464-71. Review.PMID: 16274347 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis.

    Li JJ, Xu B, Yang YJ, Ma WH, Chen JL, Qiao SB, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL.

    Chin Med J (Engl). 2006 Jul 5;119(13):1059-64.PMID: 16834923 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

    Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P.

    Lancet. 2007 Sep 15;370(9591):937-48. Review.PMID: 17869634 [PubMed - indexed for MEDLINE]Related articles

    9.

    Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis).

    Indolfi C, Pavia M, Angelillo IF.

    Am J Cardiol. 2005 May 15;95(10):1146-52.PMID: 15877984 [PubMed - indexed for MEDLINE]Related articles

    10.

    Drug-eluting stents: from randomized trials to the real world.

    Saia F, Degertekin M, Lemos PA, Serruys PW.

    Minerva Cardioangiol. 2004 Oct;52(5):349-63. Review.PMID: 15514571 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    An evidence-based approach to the use of drug-eluting stents in clinical practice.

    Kuntz RE, Wang JC, Mauri L, Cohen DJ.

    Am Heart Hosp J. 2004 Summer;2(3):132-41. Review.PMID: 15805763 [PubMed - indexed for MEDLINE]Related articles

    12.

    Drug-eluting stents.

    García-García HM, Vaina S, Tsuchida K, Serruys PW.

    Arch Cardiol Mex. 2006 Jul-Sep;76(3):297-319. Review.PMID: 17091802 [PubMed - indexed for MEDLINE]Related articles

    13.

    Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials.

    Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL.

    Am J Med. 2006 Dec;119(12):1056-61.PMID: 17145250 [PubMed - indexed for MEDLINE]Related articles

    14.

    Early experiences and clinical implications of restenosis and drug-eluting stents: Part 2.

    Chong PH, Cheng JW.

    Ann Pharmacother. 2004 May;38(5):845-52. Epub 2004 Mar 23. Review.PMID: 15039482 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.

    Whan Lee C, Kim SH, Suh J, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Park SJ.

    Catheter Cardiovasc Interv. 2008 Apr 1;71(5):594-8.PMID: 18311841 [PubMed - indexed for MEDLINE]Related articles

    16.

    Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.

    Dibra A, Kastrati A, Alfonso F, Seyfarth M, Pérez-Vizcayno MJ, Mehilli J, Schömig A.

    J Am Coll Cardiol. 2007 Feb 6;49(5):616-23. Epub 2006 Dec 4.PMID: 17276188 [PubMed - indexed for MEDLINE]Related articles

    17.

    Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.

    Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, Van Langenhove G; DELAYED RRISC (Death and Events at Long-term follow-up AnalYsis: Extended Duration of the Reduction of Restenosis In Saphenous vein grafts with Cypher stent) Investigators.

    J Am Coll Cardiol. 2007 Jul 17;50(3):261-7. Epub 2007 Jun 13.PMID: 17631219 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of drug-eluting stents on intermediate angiographic and clinical outcomes in diabetic patients: insights from randomized clinical trials.

    Kumbhani DJ, Bavry AA, Kamdar AR, Helton TJ, Bhatt DL.

    Am Heart J. 2008 Apr;155(4):640-7. Epub 2008 Feb 21. Review.PMID: 18371470 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.

    Elezi S, Dibra A, Folkerts U, Mehilli J, Heigl S, Schömig A, Kastrati A.

    J Am Coll Cardiol. 2006 Jul 18;48(2):262-7. Epub 2006 Jun 22.PMID: 16843172 [PubMed - indexed for MEDLINE]Related articles

    20.

    Percutaneous coronary intervention with everolimus-eluting stents (Xience V): systematic review and direct-indirect comparison meta-analyses with paclitaxel-eluting stents (Taxus) and sirolimus-eluting stents (Cypher).

    Biondi-Zoccai G, Lotrionte M, Moretti C, Agostoni P, Sillano D, Laudito A, Sheiban I.

    Minerva Cardioangiol. 2008 Feb;56(1):55-65. Review.PMID: 18432169 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data